STOCK TITAN
  1. Home
  2. News
  3. BZAMF

BZAM LTD - $BZAMF STOCK NEWS

Welcome to our dedicated page for BZAM news (Ticker: $BZAMF), a resource for investors and traders seeking the latest updates and insights on BZAM stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BZAM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BZAM's position in the market.

News
BZAM Announces Departure of its Chief Financial Officer
Rhea-AI Summary
BZAM Ltd. announced that Chief Financial Officer, Sean Bovingdon, will be leaving his position on April 30, 2024, to pursue other opportunities. The company has initiated a formal search process for a new CFO. Matt Milich, BZAM's CEO, will be joining the Board of Directors as a management representative. The announcement was made to ensure a smooth transition, including through the Company's results for the fiscal year ending December 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.41%
Tags
none
-
News
BZAM enters into Second Amended and Restated Credit Agreement
Rhea-AI Summary
BZAM Ltd. (BZAM) (CSE: BZAM) (US-OTC: BZAMF) has completed the acquisition of Final Bell Canada Inc. and entered into a Second Amended and Restated Credit Agreement with its Canadian lender. The SARCA incorporates the assets of FBC into the security collateral and amends the EBITDA financial covenant. The company also repaid $1 million on the fixed portion of the facility and allowed for the unsecured promissory note issued to Final Bell Holdings Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.36%
Tags
none
-
News
BZAM completes acquisition of Final Bell';s Canadian Operation; Adding Final Bell Holdings International as Strategic Shareholder
Rhea-AI Summary
BZAM Ltd. (BZAM) (CSE: BZAM) (US-OTC: BZAMF) completes acquisition of Final Bell Canada Inc. from Final Bell Holdings International Ltd., creating a Canadian cannabis powerhouse.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.94%
Tags
acquisition
News
BZAM to Acquire Final Bell';s Canadian Operation, forming 5th Largest Canadian L.P.; Adding Final Bell Holdings International as Strategic Shareholder
Rhea-AI Summary
BZAM Ltd. (CSE: BZAM) (US-OTC: BZAMF) has entered into a definitive share exchange agreement to acquire Final Bell Canada Inc. from Final Bell Holdings International Ltd.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.86%
Tags
acquisition
-
News
BZAM Ltd. Reports Third Quarter 2023 Results
Rhea-AI Summary
BZAM Ltd. (BZAM) (CSE: BZAM) (US-OTC: BZAMF) reports Q3 2023 net revenues of $21.0 million, a 112% increase from Q3 2022. Adjusted G&A expenses are at 22% of gross revenue, reduced by 30% vs. Q3 2022. Loss from operations is $12.9 million. The company completed post-merger facility consolidation and cost reduction program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.32%
Tags
earnings
-
News
BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market
Rhea-AI Summary
BZAM Ltd.'s subsidiary, The Green Organic Dutchman Ltd., has completed its first shipment of Canadian certified organic, EU GMP medical cannabis to the UK. The company will supply 4C LABS with approximately 600KG of flower annually for the next two years. 4C LABS expects to establish a dominant position in the UK medical cannabis market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.58%
Tags
none
News
BZAM Ltd. Secures Loan Facility from Chairman and Largest Shareholder';s Investment Holding Company; Terminates Previously Announced Brokered Private Placement of Units
Rhea-AI Summary
BZAM Ltd. has opted for a loan facility offered by its Chairman and largest shareholder instead of a brokered private placement. The loan is up to $3 million and will bear interest at a rate of prime plus 8% per annum. It is intended for general corporate expenses and working capital purposes. The initial tranche of $1.19 million has been funded. The loan matures no earlier than April 1, 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.56%
Tags
none
-
News
BZAM LTD. ANNOUNCES CHANGE OF AUDITOR
Rhea-AI Summary
BZAM Ltd. announces change of auditor
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
BZAM COMPLETES SALE OF MAPLE RIDGE FACILITY
Rhea-AI Summary
BZAM completes sale of Maple Ridge facility for $3.8M, reducing debt and applying $1.8M to credit facility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
BZAM LTD. COMPLETES FINAL PHASE OF POST-MERGER SYNERGY PLAN; PROVIDES POSITIVE OUTLOOK
Rhea-AI Summary
BZAM completes final phase of merger synergy plan, anticipates Q3 net revenue of $20.3M, reduces expenses and debt
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
acquisition
Stock BZAMF logo
BZAM LTD

OTC:BZAMF

BZAMF Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

BZAMF Stock Data

9.10M
50.44M
113.74%
0.02%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
Mississauga